The median glioblastoma survival rate for adults is 14.6 months, making it one of the deadliest forms of brain cancer, largely occurring in older adults. The median age at diagnosis is 65, and patient prognosis is known to decline with increased age. Christopher Hine, Ph.D., a researcher at Cleveland Clinic, has a theory that could explain why.

University of Miami neurosurgeons reflect on glioblastoma stage 4 research, outcomes and challenges.